Clinical Trial

Blazing the trail to accessibility

Radicle Science: Blazing the trail to accessibility

By Danielle Masterson

Improving the cost and speed of clinical trials has been a long time coming. While plenty of hurdles remain, Radicle Science is doing it – all the while maintaining scientific rigor and bettering the generalizability of the findings.

Picture: iStock

No bone benefit for high-dose vitamin D3

By Joseph James Whitworth

Daily supplementation with vitamin D3 at three times the standard dose provides no additional bone strength benefits in healthy infants, a clinical trial has found.

Ayurvedic extract shows joint mobility and comfort improvement in study

Ayurvedic extract shows joint mobility and comfort improvement in study

By Hank Schultz

A new study on Natreon’s AyuFlex botanical ingredient shows decreased joint pain and increased mobility among a study population of overweight adults. It’s part of the company’s strategy to support entry into new markets with hard data on its ingredients.


Could coffee curb cognitive disorders?

By David Anderson

Drinking between one and two cups of coffee per day could help prevent cognitive disorders including Alzheimer’s disease, say researchers.

The view at Vitafoods suggested CROs’ role was transitioning from a traditional support role to one that was setting the research agenda. ©iStock/shironosov


CROs in the driving seat when outlining research direction

By Will Chu

The need for robust research to validate health claims for a food ingredient has never been in doubt.  But with regulations becoming ever more stringent the role of Contract Research Organisations (CROs) appears to be changing. 

“I think that science needs parts of the process in a closed room and then many steps of the process in an open atmosphere,

Exclusive interview

EFSA’s Bernhard Url: Science should reserve one private room for open debate

By Annie Harrison-Dunn

Since taking the European Food Safety Authority (EFSA) throne last summer, Dr Bernhard Url has become something of a pin-up boy for the so-called new ‘open EFSA’. But how far exactly is this new executive director willing to take his vision of transparency?


Follow us


View more


Featured Suppliers